Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

Chest X-ray AI Algorithm Correctly Identifies Lung Disease for Dubai Health Authority
Feature | Artificial Intelligence | April 17, 2018

April 17, 2018 — The Dubai Health Authority (DHA) announced the preliminary results of a...

First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018

April 6, 2018 — Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an...

News | Endoscopes | April 02, 2018

April 2, 2018 — Results from a recent ...

Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018

March 27, 2018 — Edwards Lifesciences Corp. announced that enrollment is complete in the...

Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018

March 27, 2018 — While there are many treatment options for men with...

3-D Printed Models Improve Medical Student Training
News | Medical 3-D Printing | March 23, 2018

March 23, 2018 — A relatively inexpensive...

Average Breast Tumor Size Decreased Following Introduction of Screening
News | Breast Imaging | March 23, 2018

March 23, 2018 — The average size of ...

What is the cost of interrupting a radiologist?
News | Clinical Trials | March 20, 2018

March 20, 2018 – A first of its kind ...

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018

An Italian study featured in the March...

Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States
News | Women's Health | March 06, 2018

Older women residing in the U.S territories are less likely to receive recommended or timely care for...

dense breast tissue can lead to a missed cancer diagnosis
News | Clinical Trials | March 05, 2018

The Athena Breast Health Network has chosen Massachusetts-based Mammosphere to provide network management of medical...

Imaging Plays Key Role in Evaluating Injuries at Olympics
News | Orthopedic Imaging | February 28, 2018

February 28, 2018 — The Olympic Games give elite athletes a chance at athletic triumph, but also carry a risk of...

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound
News | Cardiovascular Ultrasound | February 26, 2018

February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are...

CyberKnife System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients
News | Radiation Therapy | February 15, 2018

February 15, 2018 — Accuray Inc. recently announced that data from a...

Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018

February 14, 2018 — Patients and their caregivers desire information about upcoming...

PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018

February 5, 2018 — Using nuclear...

Small-Cell Lung Cancer Patients Face Barriers to Standard-of-Care Treatment
News | Lung Cancer | January 29, 2018

January 23, 2018 — Despite decades of clinical research establishing chemotherapy with thoracic...

Advaxis Immunotherapy Offers Potential Combo Treatment for Anal Cancer
News | Radiation Therapy | January 26, 2018

January 26, 2018 — Advaxis Inc. (NASDAQ:ADXS), a late-stage biotechnology immunotherapy company announced that data...